MRI-Guided Stereotactic Body Radiation Therapy in Treating Patients With Liver Metastases or Liver Cancer
Condition(s):Adult Hepatocellular Carcinoma; Metastatic Malignant Neoplasm in the LiverLast Updated:February 21, 2023Completed
Hide Studies Not Open or Pending
Condition(s):Adult Hepatocellular Carcinoma; Metastatic Malignant Neoplasm in the LiverLast Updated:February 21, 2023Completed
Condition(s):Prostate Cancer; Radiotherapy Side Effect; Magnetic Resonance-linac; Stereotactic Ablative RT; Adaptive Radiotherapy; Localised Disease; Oligometastatic DiseaseLast Updated:January 10, 2022Unknown status
Condition(s):Prostate AdenocarcinomaLast Updated:December 11, 2023Active, not recruiting
Condition(s):Spinal DiseaseLast Updated:December 11, 2023Recruiting
Condition(s):Breast CancerLast Updated:March 25, 2024Recruiting
Condition(s):Safety and EfficacyLast Updated:February 28, 2024Not yet recruiting
Condition(s):CancerLast Updated:January 30, 2024Recruiting
Condition(s):Focus of the Study is MRI Sequence DevelopmentLast Updated:February 7, 2024Recruiting
Condition(s):Rectal Cancer; Head and Neck Cancer; Liver Cancer; Breast Cancer; Prostate Cancer; Oligometastasis; Esophageal CancerLast Updated:November 21, 2019Recruiting
Condition(s):Neuroendocrine Tumor of Pancreas; Multiple Endocrine Neoplasia Type 1Last Updated:December 1, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.